44.97
전일 마감가:
$45.35
열려 있는:
$45.2
하루 거래량:
615.18K
Relative Volume:
0.24
시가총액:
$4.58B
수익:
$47.30M
순이익/손실:
$-225.97M
주가수익비율:
-19.14
EPS:
-2.35
순현금흐름:
$-188.86M
1주 성능:
+1.97%
1개월 성능:
+60.52%
6개월 성능:
+31.18%
1년 성능:
+7.33%
Scholar Rock Holding Corp Stock (SRRK) Company Profile
명칭
Scholar Rock Holding Corp
전화
857-259-3860
주소
301 BINNEY STREET, CAMBRIDGE, MA
SRRK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SRRK
Scholar Rock Holding Corp
|
44.94 | 4.61B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.17 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
720.87 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.00 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
903.20 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.54 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-18 | 개시 | Wolfe Research | Outperform |
| 2025-10-09 | 개시 | BofA Securities | Buy |
| 2025-09-17 | 개시 | Barclays | Overweight |
| 2025-09-15 | 개시 | Leerink Partners | Outperform |
| 2025-08-21 | 재개 | Jefferies | Buy |
| 2025-07-30 | 재개 | Raymond James | Strong Buy |
| 2025-07-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-26 | 재확인 | H.C. Wainwright | Buy |
| 2024-10-07 | 재확인 | H.C. Wainwright | Buy |
| 2024-03-28 | 개시 | Raymond James | Strong Buy |
| 2023-10-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-04-03 | 재개 | Piper Sandler | Overweight |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2022-07-12 | 개시 | Truist | Buy |
| 2022-03-23 | 개시 | H.C. Wainwright | Buy |
| 2021-12-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-01-11 | 개시 | Credit Suisse | Outperform |
| 2021-01-06 | 개시 | JP Morgan | Overweight |
| 2020-03-12 | 개시 | Robert W. Baird | Outperform |
모두보기
Scholar Rock Holding Corp 주식(SRRK)의 최신 뉴스
FDA Warning Letter And Backup Plant Plans Could Be A Game Changer For Scholar Rock (SRRK) - Yahoo Finance
Scholar Rock (SRRK) Valuation Revisited After FDA Warning Letter to Key Manufacturing Partner - simplywall.st
Scholar Rock (SRRK) valuation after FDA manufacturing update and apitegromab resubmission plans - Yahoo Finance
Scholar Rock (NASDAQ:SRRK) Trading Up 7.8%Still a Buy? - MarketBeat
Scholar Rock Holding Corporation $SRRK Position Cut by Fisher Asset Management LLC - MarketBeat
Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away - AOL.com
Scholar Rock (NASDAQ:SRRK) Shares Gap DownShould You Sell? - MarketBeat
Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away - The Motley Fool
FDA Manufacturing Letter And Backup Plant Plans Could Be A Game Changer For Scholar Rock (SRRK) - simplywall.st
Can Scholar Rock Holding Corporation stock deliver strong Q4 earningsWeekly Market Outlook & Low Risk High Win Rate Stock Picks - Newser
Scholar Rock updates on Catalent Indiana FDA warning letter and apitegromab timeline - Investing.com Nigeria
Scholar Rock Faces FDA Warning, Plans 2026 Launch - TipRanks
Scholar Rock Updates on FDA Warning and Apitegromab Launch Plans - TradingView
Scholar Rock Holding (SRRK) Stock Analysis Report | Financials & Insights - Benzinga
Truist Financial Maintains Scholar Rock(SRRK.US) With Buy Rating - 富途牛牛
Inceptionr LLC Invests $205,000 in Scholar Rock Holding Corporation $SRRK - MarketBeat
Loomis Sayles & Co. L P Sells 17,706 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding Corporation $SRRK Shares Bought by American Century Companies Inc. - MarketBeat
Aisling Capital Management LP's Scholar Rock Holding Corp(SRRK) Holding History - GuruFocus
Universal Beteiligungs und Servicegesellschaft mbH Grows Holdings in Scholar Rock Holding Corporation $SRRK - MarketBeat
Intech Investment Management LLC Lowers Stock Holdings in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding Corporation $SRRK Shares Bought by Geode Capital Management LLC - MarketBeat
Scholar Rock Holding (SRRK): A Fresh Look at Valuation Following Recent Biotech Sector Moves - Sahm
Ensign Peak Advisors Inc Purchases 264,693 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
After tax other income/expense of Scholar Rock Holding Corp. – HAM:2QK - TradingView
Scholar Rock (NASDAQ:SRRK) Stock Rating Upgraded by Wolfe Research - MarketBeat
Eagle Health Investments LP Makes New $9.54 Million Investment in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding CorporationCommon Stock (NQ: SRRK - Markets Financial Content
Cantor Fitzgerald Lowers Earnings Estimates for Scholar Rock - MarketBeat
Will Scholar Rock Holding Corporation (2QK) stock maintain strong growthJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
Why Scholar Rock Holding Corporation (2QK) stock appears on watchlistsTrade Risk Summary & Short-Term High Return Ideas - newser.com
Using data filters to optimize entry into Scholar Rock Holding CorporationPortfolio Risk Report & Smart Swing Trading Alerts - newser.com
Using economic indicators to assess Scholar Rock Holding Corporation potential2025 Volatility Report & Smart Money Movement Alerts - newser.com
Will Scholar Rock Holding Corporation (2QK) stock attract long term capital inflowsJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - newser.com
JPMorgan Chase & Co. Boosts Scholar Rock (NASDAQ:SRRK) Price Target to $47.00 - MarketBeat
Scholar Rock (NASDAQ:SRRK) Shares Up 4.6% Following Analyst Upgrade - MarketBeat
Scholar Rock (NASDAQ:SRRK) Earns Outperform Rating from Analysts at Wolfe Research - MarketBeat
Published on: 2025-11-19 06:08:10 - newser.com
Wolfe Research Initiates Coverage of Scholar Rock Holding (SRRK) with Outperform Recommendation - Nasdaq
Scholar Rock Holding buy JPMorgan Chase & Co. - sharewise.com
Scholar Rock at Jefferies: Navigating FDA Challenges By Investing.com - Investing.com India
Scholar Rock at Jefferies: Navigating FDA Challenges - Investing.com
Scholar Rock Holding (SRRK): Wolfe Research Initiates Coverage w - GuruFocus
SRRK: JP Morgan Raises Price Target to $47, Maintains Overweight Rating | SRRK Stock News - GuruFocus
Scholar Rock (NASDAQ:SRRK) Price Target Raised to $45.00 - MarketBeat
J.P. Morgan Maintains Scholar Rock(SRRK.US) With Buy Rating, Raises Target Price to $47 - 富途牛牛
Sun Life and Kansas City Royals Raise $50K for Boys & Girls Clubs of Greater KC - Stock Titan
Scholar Rock Holding Corporation stock trend forecastTrade Entry Report & Weekly Setup with ROI Potential - newser.com
Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Wolfe Research initiates Scholar Rock stock with Outperform rating By Investing.com - Investing.com Nigeria
Scholar Rock Holding Corp (SRRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):